Does liraglutide reduce hospitalization risk compared with glimepiride in people with type 2 diabetes on metformin?

In GRADE parti...

Does tirzepatide improve kidney outcomes compared with insulin glargine in type 2 diabetes with high cardiovascular risk?

In peopl...

Does oral semaglutide reduce major adverse cardiovascular events in high-risk type 2 diabetes patients?

In people with type 2 diab...

Does weekly subcutaneous semaglutide 2.4 milligrams reduce cardiovascular events in patients with obesity without diabetes?

In pat...

Does once-weekly 2.4 milligram subcutaneous semaglutide plus lifestyle intervention reduce BMI more than lifestyle intervention alone in adolescent...

Can oral orforglipron preserve weight loss after stopping tirzepatide or semaglutide?

In selected adults without diabetes, switchi...

Does withdrawal of once-weekly subcutaneous semaglutide 2.4 milligrams lead to weight regain and reversal of cardiometabolic benefits in adults wit...

Does once-weekly tirzepatide reduce body weight in adults with obesity?

In adults with obesity, once-weekly tirzepatide reduced bo...

Can a polypill improve heart-failure treatment?

Combining three heart-failure medicines into one daily capsule improved six-month ...

Does tirzepatide improve cardiovascular outcomes and quality of life in patients with heart failure with preserved ejection fraction and obesity?